Eli Lilly offers half-price insulin as politicians pressure it over drug costs
LA TimesEli Lilly will keep selling its Humalog insulin at the existing price, but it will also sell a half-cost “authorized generic” called Insulin Lispro. Drug maker Eli Lilly & Co. will offer a half-price version of its blockbuster insulin, becoming one of the first companies to effectively cut the price of a top-selling drug amid the ongoing U.S. debate over pharmaceutical costs. Although it will continue selling its brand-name version, Humalog, at its existing price, Indianapolis-based Lilly will also sell a half-price “authorized generic” called Insulin Lispro for $137.35 a vial, or $265.20 for a five-pack of injectable pens. Last month, a Senate committee sent letters to Lilly, Novo Nordisk — the world’s biggest maker of insulin — and Sanofi asking the companies how they set insulin prices, and Sanofi CEO Olivier Brandicourt was among the pharma bosses who headed to Washington last month to testify on drug costs.
History of this topic
Column: Eli Lilly is slashing insulin prices, but hold your applause
LA Times
Lilly plans to slash some insulin prices, expand cost cap
Associated Press
Eli Lilly To Slash Some Insulin Prices, Expand Cost Cap For Insured Patients
Huff Post
Walmart launches low-priced own brand analog insulin in US
Al Jazeera
Eli Lilly’s lower-priced insulin goes on sale amid drug price debate
CNN
On rising insulin prices, lawmaker tells pharma execs: ‘Your days are numbered’
CNN
How Much Difference Will Eli Lilly's Half-Price Insulin Make?
NPR
Eli Lilly introduces generic insulin at half the price of brand-name drug
CNN
Why is the cost of insulin rising and what can people do about it?
SalonDiscover Related
)
